PubRank

Marquis P Vawter

Author PubWeight™ 57.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of microarray data using Z score transformation. J Mol Diagn 2003 6.82
2 Application of z-score transformation to Affymetrix data. Appl Bioinformatics 2003 2.56
3 Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 2004 2.53
4 Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 2004 2.33
5 Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009 1.78
6 Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2010 1.63
7 Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A 2013 1.63
8 Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007 1.59
9 Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics 2007 1.54
10 Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 2008 1.41
11 Mitochondrial involvement in psychiatric disorders. Ann Med 2008 1.38
12 Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 2009 1.36
13 Identifying gene regulatory networks in schizophrenia. Neuroimage 2010 1.34
14 Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 2008 1.32
15 CRY2 is associated with depression. PLoS One 2010 1.23
16 SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003 1.21
17 Increased fibronectin expression in sturge-weber syndrome fibroblasts and brain tissue. Pediatr Res 2003 1.21
18 Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc Natl Acad Sci U S A 2011 1.20
19 Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res 2013 1.20
20 Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 2003 1.19
21 NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr Genet 2007 1.16
22 A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome. J Med Genet 2014 1.01
23 Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One 2012 1.01
24 AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression. Exp Neurol 2002 1.00
25 Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet 2012 0.98
26 Next generation sequence analysis and computational genomics using graphical pipeline workflows. Genes (Basel) 2012 0.97
27 The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis 2011 0.95
28 Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med Genomics 2009 0.93
29 Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. J Neurosci 2013 0.90
30 P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1. PLoS One 2012 0.89
31 Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One 2011 0.87
32 Application of microarray technology in primate behavioral neuroscience research. Methods 2006 0.86
33 Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophr Res 2011 0.83
34 Changes in hippocampal gene expression after neuroprotective activation of group I metabotropic glutamate receptors. Brain Res Mol Brain Res 2003 0.80
35 Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica. Psychiatr Genet 2009 0.79
36 Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. Genomics 2013 0.78
37 Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia. Dis Markers 2013 0.78